Olga DelaRosa

2.9k total citations
34 papers, 2.2k citations indexed

About

Olga DelaRosa is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Olga DelaRosa has authored 34 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 18 papers in Genetics and 8 papers in Oncology. Recurrent topics in Olga DelaRosa's work include Mesenchymal stem cell research (18 papers), Immune Cell Function and Interaction (13 papers) and T-cell and B-cell Immunology (11 papers). Olga DelaRosa is often cited by papers focused on Mesenchymal stem cell research (18 papers), Immune Cell Function and Interaction (13 papers) and T-cell and B-cell Immunology (11 papers). Olga DelaRosa collaborates with scholars based in Spain, Germany and Belgium. Olga DelaRosa's co-authors include Eleuterio Lombardo, Raquel Tarazona, Rafael Solana, Wilfried Dalemans, Ramón Menta, Pablo Mancheño‐Corvo, Cristina M. Ramírez, Javier G. Casado, Corona Alonso and Dirk Büscher and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Olga DelaRosa

34 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga DelaRosa Spain 22 1.1k 966 478 420 359 34 2.2k
Roberta Angeli Italy 16 1.4k 1.3× 1.7k 1.8× 643 1.3× 597 1.4× 527 1.5× 19 3.5k
Anna Corcione Italy 25 1.3k 1.2× 1.2k 1.3× 493 1.0× 620 1.5× 688 1.9× 56 3.0k
Abderrahim Naji France 16 1.1k 1.0× 886 0.9× 512 1.1× 513 1.2× 245 0.7× 19 2.1k
Soufiane Ghannam France 8 844 0.8× 633 0.7× 359 0.8× 355 0.8× 236 0.7× 11 1.7k
Chunliang Xu United States 19 1.2k 1.1× 969 1.0× 323 0.7× 1000 2.4× 460 1.3× 29 3.1k
Dobroslav Kyurkchiev Bulgaria 19 855 0.8× 498 0.5× 432 0.9× 354 0.8× 245 0.7× 52 1.7k
Kelen Cristina Ribeiro Malmegrim Brazil 24 778 0.7× 471 0.5× 665 1.4× 508 1.2× 239 0.7× 63 2.0k
Assia Eljaafari France 25 632 0.6× 806 0.8× 332 0.7× 422 1.0× 359 1.0× 57 2.1k
Ivett Jelinek Hungary 8 1.6k 1.5× 755 0.8× 723 1.5× 703 1.7× 240 0.7× 13 2.6k
Steve Devine United States 13 1.7k 1.6× 325 0.3× 738 1.5× 481 1.1× 268 0.7× 22 2.3k

Countries citing papers authored by Olga DelaRosa

Since Specialization
Citations

This map shows the geographic impact of Olga DelaRosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga DelaRosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga DelaRosa more than expected).

Fields of papers citing papers by Olga DelaRosa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga DelaRosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga DelaRosa. The network helps show where Olga DelaRosa may publish in the future.

Co-authorship network of co-authors of Olga DelaRosa

This figure shows the co-authorship network connecting the top 25 collaborators of Olga DelaRosa. A scholar is included among the top collaborators of Olga DelaRosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga DelaRosa. Olga DelaRosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheung, Tik Shing, Chiara Giacomini, Matteo Cereda, et al.. (2023). Apoptosis in mesenchymal stromal cells activates an immunosuppressive secretome predicting clinical response in Crohn’s disease. Molecular Therapy. 31(12). 3531–3544. 25 indexed citations
2.
Avivar‐Valderas, Alvaro, Cristina Martín-Martín, Cristina M. Ramírez, et al.. (2019). Dissecting Allo-Sensitization After Local Administration of Human Allogeneic Adipose Mesenchymal Stem Cells in Perianal Fistulas of Crohn's Disease Patients. Frontiers in Immunology. 10. 1244–1244. 33 indexed citations
3.
Mancheño‐Corvo, Pablo, Mercedes López‐Santalla, Ramón Menta, et al.. (2017). Intralymphatic Administration of Adipose Mesenchymal Stem Cells Reduces the Severity of Collagen-Induced Experimental Arthritis. Frontiers in Immunology. 8. 462–462. 19 indexed citations
4.
López‐Santalla, Mercedes, Ramón Menta, Pablo Mancheño‐Corvo, et al.. (2016). Adipose‐derived mesenchymal stromal cells modulate experimental autoimmune arthritis by inducing an early regulatory innate cell signature. Immunity Inflammation and Disease. 4(2). 213–224. 20 indexed citations
5.
Álvaro‐Gracia, José María, Juan Ángel Jover, Rosario García‐Vicuña, et al.. (2016). Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Annals of the Rheumatic Diseases. 76(1). 196–202. 202 indexed citations
6.
Álvarez, Verónica, Rebeca Blázquez, Francisco M. Sánchez‐Margallo, et al.. (2015). Estudio comparativo del aislamiento de exosomas derivados de células madre mesenquimales humanas para uso clínico. Acta bioquímica clínica latinoamericana. 49(3). 311–320. 3 indexed citations
8.
Barrio, Laura, Víctor D. Cuevas, Ramón Menta, et al.. (2014). Human adipose tissue–derived mesenchymal stromal cells promote B-cell motility and chemoattraction. Cytotherapy. 16(12). 1692–1699. 6 indexed citations
9.
Menta, Ramón, Pablo Mancheño‐Corvo, Cristina M. Ramírez, et al.. (2014). Tryptophan concentration is the main mediator of the capacity of adipose mesenchymal stromal cells to inhibit T-lymphocyte proliferation in vitro. Cytotherapy. 16(12). 1679–1691. 23 indexed citations
10.
DelaRosa, Olga, Wilfried Dalemans, & Eleuterio Lombardo. (2012). Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Current Opinion in Biotechnology. 23(6). 978–983. 50 indexed citations
11.
Mancheño‐Corvo, Pablo, Olga DelaRosa, Santos Mañes, et al.. (2011). APRIL and BAFF Proteins Increase Proliferation of Human Adipose-Derived Stem Cells Through Activation of Erk1/2 MAP Kinase. Tissue Engineering Part A. 18(7-8). 852–859. 21 indexed citations
12.
DelaRosa, Olga, Beatriz Sánchez-Correa, Sara Morgado, et al.. (2011). Human Adipose-Derived Stem Cells Impair Natural Killer Cell Function and Exhibit Low Susceptibility to Natural Killer-Mediated Lysis. Stem Cells and Development. 21(8). 1333–1343. 92 indexed citations
13.
DelaRosa, Olga, Eleuterio Lombardo, Pablo Mancheño‐Corvo, et al.. (2009). Requirement of IFN-γ–Mediated Indoleamine 2,3-Dioxygenase Expression in the Modulation of Lymphocyte Proliferation by Human Adipose–Derived Stem Cells. Tissue Engineering Part A. 15(10). 2795–2806. 228 indexed citations
14.
Lombardo, Eleuterio, Olga DelaRosa, Pablo Mancheño‐Corvo, et al.. (2008). Toll-like Receptor–Mediated Signaling in Human Adipose-Derived Stem Cells: Implications for Immunogenicity and Immunosuppressive Potential. Tissue Engineering Part A. 15(7). 1579–1589. 123 indexed citations
15.
Casado, Javier G., Olga DelaRosa, Graham Pawelec, et al.. (2008). Correlation of effector function with phenotype and cell division after in vitro differentiation of naive MART-1-specific CD8+ T cells. International Immunology. 21(1). 53–62. 7 indexed citations
16.
DelaRosa, Olga, Graham Pawelec, Esther Peralbo, et al.. (2006). Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology. 7(5-6). 471–481. 104 indexed citations
17.
Tarazona, Raquel, et al.. (2004). Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?. Cancer Immunology Immunotherapy. 53(10). 911–24. 18 indexed citations
18.
Tarazona, Raquel, et al.. (2003). Human NKT cells in health and disease. 7 indexed citations
19.
Tarazona, Raquel, Olga DelaRosa, Javier G. Casado, et al.. (2002). NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56. AIDS. 16(2). 197–200. 38 indexed citations
20.
Tarazona, Raquel, et al.. (2001). Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mechanisms of Ageing and Development. 121(1-3). 77–88. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026